Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

Many eczema patients skip the mental health talk. Learn how to discuss anxiety and depression with your dermatologist to unlock better treatment options and systemic therapies.

Researchers are evaluating whether biologic therapies for severe asthma reduce the risk for osteoarthritis progression in ...

Galderma has significantly raised its peak annual sales estimate for Nemluvio (nemolizumab) to more than $4 billion | Galderma has doubled its peak annual sales estimate for Nemluvio (nemolizumab) to ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful ...

Dr Geng discusses his research from AAAAI Annual Meeting, which explored the relationship between atopic dermatitis and comorbid atopic conditions.

Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. | Two new cancer cases have ...

Kyowa Kirin on Tuesday said it is discontinuing all ongoing trials of its experimental drug to treat ​skin conditions after the company concluded that the potential risks ‌may outweigh the benefits ...

PHB-050 is currently in a Phase 1 clinical trial for food allergy. The ongoing trial is expected to generate key data on safety, pharmacokinetics and the potential to rapidly reduce circulating IgE ...

Lynk Pharmaceuticals has reported another phase 3 win in China for its next-gen JAK inhibitor, this time hitting skin clearance goals among patients with eczema. | Lynk Pharmaceuticals has reported ...

Among patients with moderate to severe atopic dermatitis, APG777 produced significant reductions in disease severity at 16 ...